Biotech

All Articles

ArsenalBio raises $325M, pivots away from former lead asset

.Collection Biosciences is actually carrying on up. The tissue therapy business has added $325 milli...

Lilly- supported weight reduction biotech reports IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...

Aelis' cannabis usage medication flunks period 2b, steering Indivior to re-think $100M possibility

.Aelis Farma's chances of protecting a fast, beneficial selection on a $100 thousand option settleme...

ProKidney halts stage 3 trial certainly not needed to have for cell therapy authorization

.ProKidney has actually quit one of a pair of phase 3 tests for its tissue treatment for kidney cond...

Vaxcyte surges on 'sensational' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what professionals named "remarkable" phase 1/2 data for its 31-valent pneumococca...

Recursion's mind disease test reveals little proof of effectiveness

.Recursion has discovered with a very early examination of its own tech-enabled technique to drug ex...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Phone it a case of good chemical make up: Acepodia, a biotech based upon Nobel Prize-winning scienc...

Praxis epilepsy medicine minimizes confiscations in stage 2 hearing

.Praxis Preciseness Medicines has racked up yet another midphase succeed in epilepsy this year, alon...

Three directors resign as Dyne blog posts mixed information for DMD prospect

.After running away a professional hold several years back, Dyne Rehab has actually uncovered brand ...

Arrowhead fires off stage 3 data in unusual metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand before a prospective showdown along with I...